Kenija - anglų - Pharmacy and Poisons Board

norbrook kenya ltd old limuru road karuri p.o box 1287 00606 nairobi - procaine penicillin and dihydrostreptomycin… - suspension for injection - procaine penicillin200mg/ml and… - antibacterials for systemic use:

Malaizija - anglų - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

vemedim sdn bhd - procaine penicillin; dihydrostreptomycin sulphate -

Saudo Arabija - anglų - SFDA (Saudi Food and Drug Authority)- الهيئة العامة للغذاء والدواء

procaine benzylpenicillin, dihydrostreptomycin sulphate - suspension for injection - 200.200 mg

Filipinai - anglų - FDA (Food And Drug Administration)

vet specialists, inc.; distributor: vet specialists, inc. - procaine benzylpenicillin , dihydrostreptomycin (vet.) - suspension for injection (im/sc) - 200 mg/200 mg per ml

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

hospira nz ltd - procaine hydrochloride 2%{relative};   - solution for injection - 2% w/v - active: procaine hydrochloride 2%{relative}   excipient: sodium chloride water for injection

Naujoji Zelandija - anglų - Medsafe (Medicines Safety Authority)

astrazeneca limited - procaine hydrochloride 2%;  ;   - solution for injection - 2 % - active: procaine hydrochloride 2%     excipient: hydrochloric acid sodium chloride water for injection

Izraelis - anglų - Ministry of Health

comex ltd - dihydrostreptomycin sulfate 250 mg/ml; procaine benzylpenicillin 200 mg/ml - suspension for injection - treatment of infection caused orassociated with organisms sensitive to penicillin and/or streptomycin in cattle, horses, pigs and sheep.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

general injectables & vaccines, inc - chloroprocaine hydrochloride (unii: lt7z1yw11h) (chloroprocaine - unii:5yvb0pot2h) - chloroprocaine hydrochloride 10 mg in 1 ml - nesacaine 1% and 2% injections, in multidose vials with methylparaben as preservative, are indicated for the production of local anesthesia by infiltration and peripheral nerve block. they are not to be used for lumbar or caudal epidural anesthesia. nesacaine-mpf 2% and 3% injections, in single dose vials without preservative and without edta, are indicated for the production of local anesthesia by infiltration, peripheral and central nerve block, including lumbar and caudal epidural blocks. nesacaine and nesacaine-mpf injections are not to be used for subarachnoid administration. nesacaine and nesacaine-mpf injections are contraindicated in patients hypersensitive (allergic) to drugs of the paba ester group. lumbar and caudal epidural anesthesia should be used with extreme caution in persons with the following conditions: existing neurological disease, spinal deformities, septicemia, and severe hypertension.

Australija - anglų - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - benzathine benzylpenicillin tetrahydrate, quantity: 1200000 usp unit - injection, suspension - excipient ingredients: water for injections; sodium citrate; carmellose sodium; povidone; propyl hydroxybenzoate; methyl hydroxybenzoate; lecithin - intramuscular benzathine penicillin is indicated in the treatment of infections due to penicillin-sensitive micro-organisms that are susceptible to the low and very prolonged serum levels common to this particular dosage form. therapy should be guided by bacteriological studies (including sensitivity tests) and by clinical response. the following infections will usually respond to adequate dosage of intramuscular benzathine penicillin: streptococcal infections (group a - without bacteraemia). mild-to-moderate infections of the upper respiratory tract (e.g. pharyngitis). venereal infections - syphilis, yaws, bejel and pinta. medical conditions in which benzathine penicillin therapy is indicated as prophylaxis: rheumatic fever and/or chorea - prophylaxis with benzathine penicillin has proven effective in preventing recurrence of these conditions. it has also been used as a follow-up prophylactic therapy for preventing rheumatic heart disease and acute glomerulonephritis.

Jungtinės Valstijos - anglų - NLM (National Library of Medicine)

hf acquisition co llc, dba healthfirst - chloroprocaine hydrochloride (unii: lt7z1yw11h) (chloroprocaine - unii:5yvb0pot2h) - nesacaine 1% and 2% injections, in multidose vials with methylparaben as preservative, are indicated for the production of local anesthesia by infiltration and peripheral nerve block. they are not to be used for lumbar or caudal epidural anesthesia. nesacaine-mpf 2% and 3% injections, in single dose vials without preservative and without edta, are indicated for the production of local anesthesia by infiltration, peripheral and central nerve block, including lumbar and caudal epidural blocks. nesacaine and nesacaine-mpf injections are not to be used for subarachnoid administration. nesacaine and nesacaine-mpf injections are contraindicated in patients hypersensitive (allergic) to drugs of the paba ester group. lumbar and caudal epidural anesthesia should be used with extreme caution in persons with the following conditions: existing neurological disease, spinal deformities, septicemia, and severe hypertension.